{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:01:57Z","timestamp":1789106517287,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFB4600600"],"award-info":[{"award-number":["2022YFB4600600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82300423"],"award-info":[{"award-number":["No. 82300423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Research Institutions Innovation Ability Construction Stability Support Topics","award":["KD02202019"],"award-info":[{"award-number":["KD02202019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-025-00993-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:21:33Z","timestamp":1751372493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An engineered hypoxia-response promoter for human umbilical cord-derived mesenchymal stem cell-based therapeutics"],"prefix":"10.1186","volume":"25","author":[{"given":"Song","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qikun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzheng","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"8","key":"993_CR1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"21","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke Statistics-2023 update: A report from the American heart association. Circulation Feb. 2023;21(8):e93\u2013621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123.","journal-title":"Circulation Feb"},{"key":"993_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yjmcc.2022.06.013","volume":"171","author":"J Fang","year":"2022","unstructured":"Fang J, Li JJ, Zhong X, et al. Engineering stem cell therapeutics for cardiac repair. J Mol Cell Cardiol Oct. 2022;171:56\u201368. https:\/\/doi.org\/10.1016\/j.yjmcc.2022.06.013.","journal-title":"J Mol Cell Cardiol Oct"},{"issue":"6","key":"993_CR3","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1159\/000492704","volume":"48","author":"P Muller","year":"2018","unstructured":"Muller P, Lemcke H, David R. Stem cell therapy in heart Diseases - cell types, mechanisms and improvement strategies. Cell Physiol Biochem. 2018;48(6):2607\u201355. https:\/\/doi.org\/10.1159\/000492704.","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"993_CR4","doi-asserted-by":"publisher","first-page":"30015","DOI":"10.3390\/ijms161226215","volume":"16","author":"KJ Rhee","year":"2015","unstructured":"Rhee KJ, Lee JI, Eom YW. Mesenchymal stem Cell-Mediated effects of tumor support or suppression. Int J Mol Sci Dec. 2015;16(12):30015\u201333. https:\/\/doi.org\/10.3390\/ijms161226215.","journal-title":"Int J Mol Sci Dec"},{"key":"993_CR5","doi-asserted-by":"publisher","first-page":"1958941","DOI":"10.1155\/2019\/1958941","volume":"2019","author":"J Ni","year":"2019","unstructured":"Ni J, Liu X, Yin Y, Zhang P, Xu YW, Liu Z. Exosomes derived from TIMP2-Modified human umbilical cord mesenchymal stem cells enhance the repair effect in rat model with myocardial infarction possibly by the Akt\/Sfrp2 pathway. Oxid Med Cell Longev. 2019;2019:1958941. https:\/\/doi.org\/10.1155\/2019\/1958941.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"993_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11427-019-1575-x","volume":"64","author":"Q Wang","year":"2021","unstructured":"Wang Q, He X, Wang B, et al. Injectable collagen scaffold promotes swine myocardial infarction recovery by long-term local retention of transplanted human umbilical cord mesenchymal stem cells. Sci China Life Sci Feb. 2021;64(2):269\u201381. https:\/\/doi.org\/10.1007\/s11427-019-1575-x.","journal-title":"Sci China Life Sci Feb"},{"issue":"11","key":"993_CR7","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/cbin.11664","volume":"45","author":"Z Wang","year":"2021","unstructured":"Wang Z, Gao D, Wang S, Lin H, Wang Y, Xu W. Exosomal microRNA-1246 from human umbilical cord mesenchymal stem cells potentiates myocardial angiogenesis in chronic heart failure. Cell Biol Int Nov. 2021;45(11):2211\u201325. https:\/\/doi.org\/10.1002\/cbin.11664.","journal-title":"Cell Biol Int Nov"},{"issue":"11","key":"993_CR8","doi-asserted-by":"publisher","first-page":"e49645","DOI":"10.7759\/cureus.49645","volume":"15","author":"MR Abouzid","year":"2023","unstructured":"Abouzid MR, Ali K, Kamel I, Esteghamati S, Saleh A, Ghanim M. The safety and efficacy of human umbilical Cord-Derived mesenchymal stem cells in patients with heart failure and myocardial infarction: A Meta-Analysis of clinical trials. Cureus Nov. 2023;15(11):e49645. https:\/\/doi.org\/10.7759\/cureus.49645.","journal-title":"Cureus Nov"},{"issue":"1","key":"993_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13287-022-02919-8","volume":"11","author":"S Gao","year":"2022","unstructured":"Gao S, Jin Y, Ma J, et al. Preclinical study of human umbilical cord mesenchymal stem cell sheets for the recovery of ischemic heart tissue. Stem Cell Res Ther Jun. 2022;11(1):252. https:\/\/doi.org\/10.1186\/s13287-022-02919-8.","journal-title":"Stem Cell Res Ther Jun"},{"issue":"4","key":"993_CR10","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.3892\/mmr.2018.9375","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yao L, Yang J, Wang Z, Du G. PI3K\/Akt and HIF\u20131 signaling pathway in hypoxia\u2013ischemia (Review). Mol Med Rep Oct. 2018;18(4):3547\u201354. https:\/\/doi.org\/10.3892\/mmr.2018.9375.","journal-title":"Mol Med Rep Oct"},{"issue":"5","key":"993_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W. HIF-1alpha pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B Sep. 2015;5(5):378\u201389. https:\/\/doi.org\/10.1016\/j.apsb.2015.05.007.","journal-title":"Acta Pharm Sin B Sep"},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3332\/ecancer.2017.751","volume":"11","author":"B Javan","year":"2017","unstructured":"Javan B, Shahbazi M. Hypoxia-inducible tumour-specific promoters as a dual-targeting transcriptional regulation system for cancer gene therapy. Ecancermedicalscience. 2017;11:751. https:\/\/doi.org\/10.3332\/ecancer.2017.751.","journal-title":"Ecancermedicalscience"},{"issue":"19","key":"993_CR13","doi-asserted-by":"publisher","first-page":"e38857","DOI":"10.1016\/j.heliyon.2024.e38857","volume":"15","author":"E Alwohoush","year":"2024","unstructured":"Alwohoush E, Ismail MA, Al-Kurdi B, et al. Effect of hypoxia on proliferation and differentiation of induced pluripotent stem cell-derived mesenchymal stem cells. Heliyon Oct. 2024;15(19):e38857. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38857.","journal-title":"Heliyon Oct"},{"issue":"12","key":"993_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1302\/2046-3758.1312.BJR-2024-0136.R2","volume":"12","author":"QM Huang","year":"2024","unstructured":"Huang QM, Zhuo YQ, Duan ZX, et al. Long-term hypoxic atmosphere enhances the stemness, immunoregulatory functions, and therapeutic application of human umbilical cord mesenchymal stem cells. Bone Joint Res Dec. 2024;12(12):764\u201378. https:\/\/doi.org\/10.1302\/2046-3758.1312.BJR-2024-0136.R2.","journal-title":"Bone Joint Res Dec"},{"key":"993_CR15","doi-asserted-by":"publisher","unstructured":"Kwon SY, Chun SY, Ha YS, et al. Hypoxia enhances cell properties of human mesenchymal stem cells. Tissue Eng Regen Med. Oct 2017;14(5):595\u2013604. https:\/\/doi.org\/10.1007\/s13770-017-0068-8.","DOI":"10.1007\/s13770-017-0068-8"},{"key":"993_CR16","doi-asserted-by":"publisher","unstructured":"Park SE, Kim H, Kwon S, et al. Pressure Stimuli Improve the Proliferation of Wharton\u2019s Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions. Int J Mol Sci Sep. 2020;25(19). https:\/\/doi.org\/10.3390\/ijms21197092.","DOI":"10.3390\/ijms21197092"},{"issue":"2","key":"993_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov Feb. 2008;7(2):168\u201381. https:\/\/doi.org\/10.1038\/nrd2467.","journal-title":"Nat Rev Drug Discov Feb"},{"key":"993_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-94-007-7359-2_1","volume":"75","author":"R McKenna","year":"2014","unstructured":"McKenna R, Frost SC. Overview of the carbonic anhydrase family. Subcell Biochem. 2014;75:3\u20135. https:\/\/doi.org\/10.1007\/978-94-007-7359-2_1.","journal-title":"Subcell Biochem"},{"key":"993_CR19","doi-asserted-by":"publisher","unstructured":"Kaluz S, Kaluzova M, Liao SY, Lerman M, Stanbridge EJ. Apr. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochim biophys acta. 2009;1795(2):162\u201372. https:\/\/doi.org\/10.1016\/j.bbcan.2009.01.001","DOI":"10.1016\/j.bbcan.2009.01.001"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"144839","DOI":"10.1016\/j.scitotenv.2020.144839","volume":"1","author":"HQ Chen","year":"2021","unstructured":"Chen HQ, Chen DJ, Li Y, et al. DNA methylation and hydroxymethylation associated with gene expression regulatory network during 3-methylcholanthrene induced lung cell malignant transformation. Sci Total Environ Jun. 2021;1:771:144839. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.144839.","journal-title":"Sci Total Environ Jun"},{"issue":"4","key":"993_CR21","first-page":"1121","volume":"26","author":"L Jakubickova","year":"2005","unstructured":"Jakubickova L, Biesova Z, Pastorekova S, Kettmann R, Pastorek J. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines. Int J Oncol Apr. 2005;26(4):1121\u20137.","journal-title":"Int J Oncol Apr"},{"issue":"4","key":"993_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbrc.2008.03.147","volume":"13","author":"S Kaluz","year":"2008","unstructured":"Kaluz S, Kaluzova M, Stanbridge EJ. Rational design of minimal hypoxia-inducible enhancers. Biochem Biophys Res Commun Jun. 2008;13(4):613\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2008.03.147.","journal-title":"Biochem Biophys Res Commun Jun"},{"issue":"3","key":"993_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1006\/geno.1996.0223","volume":"1","author":"R Opavsky","year":"1996","unstructured":"Opavsky R, Pastorekova S, Zelnik V, et al. Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics May. 1996;1(3):480\u20137. https:\/\/doi.org\/10.1006\/geno.1996.0223.","journal-title":"Genomics May"},{"issue":"5","key":"993_CR24","first-page":"917","volume":"1","author":"S Kaluz","year":"2003","unstructured":"Kaluz S, Kaluzova M, Stanbridge EJ. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res Mar. 2003;1(5):917\u201322.","journal-title":"Cancer Res Mar"},{"key":"993_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2017.08.033","volume":"15","author":"JI Suzuki","year":"2017","unstructured":"Suzuki JI, Dezawa M, Kitada M. Prolonged but non-permanent expression of a transgene in ependymal cells of adult rats using an adenovirus-mediated transposon gene transfer system. Brain Res Nov. 2017;15:1675:20\u20137. https:\/\/doi.org\/10.1016\/j.brainres.2017.08.033.","journal-title":"Brain Res Nov"},{"issue":"1","key":"993_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/21655979.2019.1684863","volume":"10","author":"ZJ Xu","year":"2019","unstructured":"Xu ZJ, Jia YL, Wang M, et al. Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells. Bioengineered Dec. 2019;10(1):548\u201360. https:\/\/doi.org\/10.1080\/21655979.2019.1684863.","journal-title":"Bioengineered Dec"},{"issue":"8","key":"993_CR27","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","volume":"15","author":"PJ Ratcliffe","year":"2013","unstructured":"Ratcliffe PJ. Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J Physiol Apr. 2013;15(8):2027\u201342. https:\/\/doi.org\/10.1113\/jphysiol.2013.251470.","journal-title":"J Physiol Apr"},{"issue":"12","key":"993_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL. Hypoxia-Inducible factors: master regulators of Cancer progression. Trends Cancer Dec. 2016;2(12):758\u201370. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.016.","journal-title":"Trends Cancer Dec"},{"key":"993_CR29","doi-asserted-by":"publisher","unstructured":"Takacova M, Barathova M, Zatovicova M, et al. Carbonic anhydrase IX-Mouse versus human. Int J Mol Sci Dec. 2019;30(1). https:\/\/doi.org\/10.3390\/ijms21010246.","DOI":"10.3390\/ijms21010246"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-00993-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-025-00993-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-025-00993-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:03:32Z","timestamp":1751414612000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/s12896-025-00993-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1186\/s12896-025-00993-3","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}